Metomidate
Chemical compound
From Wikipedia, the free encyclopedia
Metomidate is a non-barbiturate imidazole that was discovered by Janssen Pharmaceutica in 1965[1] and under the names (Hypnodil, Nokemyl) is sold as a sedative-hypnotic drug used in Europe to treat humans and for veterinary purposes.[2]
Legal status
- In general: ℞ (Prescription only)
| Clinical data | |
|---|---|
| ATCvet code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.023.971 |
| Chemical and physical data | |
| Formula | C13H14N2O2 |
| Molar mass | 230.267 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
11C-labelled metomidate (11C-metomidate), may be used with positron emission tomography (PET). For instance, to detect tumors of adrenocortical origin.[3][4]